Focal Therapeutics
Aliso Viejo, US · Delaware corporation · 1 known investors
Founders & leadership
GD
George D HermannExecutive
SG
Steven GexExecutive
SN
Steven NaberExecutive
GS
Gail S LebovicNamed on SEC filing
Board
SS
Sharon StevensoninBoard directorCo-Founder, Managing Director, Venture Partner at Okapi Venture Capital
RB
Robert BrownellBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 3 rounds · 2013–2016
▶$48.9KraisedJan 2017 · 2 investors · Other Health CareRule 506(b)
▶$48.9KraisedJan 2017 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven NaberExecutive Officer
- Robert BrownellDirector
- Gail S. LebovicExecutive Officer, Director
- Steven GexExecutive Officer, Director
- Sharon StevensonDirector
- George D. HermannExecutive Officer, Director
- Offering amount
- $48.9K
- Amount sold
- $48.9K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedMar 2016 · 28 investors · Other Health CareRule 506(b)
▶$3.8MraisedMar 2016 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gail S LebovicExecutive Officer, Director
- George D HermannExecutive Officer
- Robert BrownellDirector
- Steven GexExecutive Officer, Director
- Sharon StevensonDirector
- Steven NaberExecutive Officer
- Offering amount
- $5M
- Amount sold
- $3.8M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedSep 2014 · 22 investors · Other Health CareRule 506(b)
▶$7.8MraisedSep 2014 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven GexExecutive Officer, Director
- Robert BrownellDirector
- George D HermannExecutive Officer, Director
- Steven NaberExecutive Officer
- Sharon StevensonDirector
- Gail S LebovicDirector
- Offering amount
- $10.1M
- Amount sold
- $7.8M
- First sale
- Aug 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Focal Therapeutics's investors?
- Focal Therapeutics's investors include Okapi Venture Capital.
- How much funding has Focal Therapeutics raised?
- Focal Therapeutics has disclosed $11.7M raised across 3 rounds.
- Where is Focal Therapeutics headquartered?
- Focal Therapeutics is headquartered in Aliso Viejo, US.